Cagrilintide and Semaglutide Interaction

Synergistic
Researched 95% confidence

Cagrilintide and Semaglutide have a synergistic interaction with 95% confidence. CagriSema combination achieves enhanced weight loss through complementary GLP-1 and amylin pathways. Both compounds affect the gi tract and pancreas, so monitoring these systems is recommended.

Compound Profiles

Cagrilintide

Long-Acting Amylin Receptor Agonist | Weight Loss & Diabetes

Subcutaneous injection enables optimal bioavailability, targeting dual amylin and calcitonin receptors for satiety and metabolic regulation. Enhances insulin sensitivity and controls gastric emptying.

Half-life: ~7 days (159-195 hours) Typical dose: 2.4mg weekly (after escalation) weight loss, metabolic
amylin receptor cardiotoxicinsulin sensitizing
View full profile

Semaglutide

GLP-1 Receptor Agonist | Weight Loss & Diabetes

Mimics native GLP-1, binding to receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite via hypothalamic pathways..

Half-life: ~7 days (168 hours) Typical dose: 0.25mg starting, titrate to 1-2.4mg weekly weight loss, metabolic
glp1 receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pancreas
low

Frequently Asked Questions

Can I take Cagrilintide with Semaglutide?

Yes, Cagrilintide and Semaglutide can generally be taken together. CagriSema combination achieves enhanced weight loss through complementary GLP-1 and amylin pathways.

Is Cagrilintide and Semaglutide safe together?

Based on documented research, this combination is considered synergistic. No critical safety flags identified for this pair.

What are the interactions between Cagrilintide and Semaglutide?

CagriSema combination achieves enhanced weight loss through complementary GLP-1 and amylin pathways. This assessment has 95% confidence and is based on documented research data.

How should I time Cagrilintide and Semaglutide?

Cagrilintide has a half-life of ~7 days (159-195 hours) and Semaglutide has a half-life of ~7 days (168 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Cagrilintide vs Semaglutide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.